Meta description: This report provides a concise regulatory overview of the OsseoFit Stemless Anatomic Shoulder System trial, noting not yet recruiting status and sponsor details for device stakeholders.
Publication date context: February 20, 2026. This report summarizes a clinical trials listing for the OsseoFit Stemless Anatomic Shoulder System and outlines what it means for regulators, surgeons, and manufacturers. The device is listed with two interventions, OsseoFit Stemless Inlay and OsseoFit Stemless Onlay, and the sponsor is Zimmer Biomet. The record status is Not yet recruiting and is hosted on ClinicalTrials.gov under NCT07421245. For official record and updates see the linked ClinicalTrials.gov entry.
What changed in the OsseoFit Stemless Anatomic Shoulder System listing?
The listing documents two device interventions under the OsseoFit Stemless family: stemless Inlay and stemless Onlay. Both are associated with a stemless anatomic shoulder approach. The sponsor named is Zimmer Biomet. The record status is Not yet recruiting, and the conditions listed include Shoulder Injuries, Shoulder Pain, Shoulder Fractures, Shoulder Arthritis, and Shoulder Disease. The information is current as of the source time noted on ClinicalTrials.gov, and the primary source link is included below.
As with any early stage trial entry, recruitment has not started, and the listing reflects planning and device development activity rather than active enrollment. For stakeholders, this signals preparation steps in device evaluation and potential future study design.
Who is affected by this listing?
Stakeholders in shoulder arthroplasty research and practice may monitor this record. Surgeons evaluating future stemless options may consider how anatomic inlays and onlays fit into procedural planning. Regulatory teams will track statuses that influence potential market entry dates and data collection plans. The sponsor Zimmer Biomet is a major orthopedic device manufacturer with global operations, which may shape follow up actions and disclosure requirements.
Linkage to the ClinicalTrials.gov record supports traceability for regulators and clinicians who seek official details about the study design, inclusion criteria, and anticipated milestones.
What is the regulatory context for this trial?
The listing aligns with standard public records for devices under development that are intended for shoulder reconstruction. The Not yet recruiting status indicates the trial is in early phases, with no enrollment yet initiated. In regulatory practice this status can affect planning for future submissions, safety assessments, and performance data collection. The OsseoFit stemless concept is described as two configuration options intended for anatomic joint replacement, but the lack of trial data means that no conclusions about safety or effectiveness can be drawn from the listing alone.
What does Not yet recruiting mean for decision making?
Not yet recruiting means the study has not opened sites or enrolled participants. Stakeholders should anticipate updates as the trial progresses and enrolls participants if the plan remains on track. Regulators will expect complete documentation and transparent reporting when the study transitions to later phases.
What are the OsseoFit Stemless Inlay and Onlay?
Interventions listed include Device: OsseoFit Stemless Inlay and Device: OsseoFit Stemless Onlay. These terms denote components of a stemless shoulder system that may be studied for anatomic arthroplasty. The listing does not provide performance metrics or comparative data at this stage.
Who sponsors and what is the status?
Sponsor: Zimmer Biomet. Trial status: Not yet recruiting. The ClinicalTrials.gov identifier for this listing is NCT07421245. No enrollment data are present in the record at this time. This information helps regulators and potential investigators track development progress and anticipate future updates.
FAQ
- 1. What is the OsseoFit Stemless Shoulder System?
- 2. What does Not yet recruiting mean?
- 3. Where can I find the official record?
Conclusion
The OsseoFit Stemless Anatomic Shoulder System listing shows a two device approach under development with Zimmer Biomet as sponsor. The Not yet recruiting status indicates early stage work and no participant enrollment at this time. Stakeholders should monitor the ClinicalTrials.gov entry for future milestones and regulatory updates.
For professionals seeking the most current details, the official record is the ClinicalTrials.gov page linked earlier in this article. This post offers a regulatory view based solely on the listing information.
Disclaimer
This article is intended for regulatory and clinical professionals. It is not legal advice. It does not replace official regulatory guidance or the clinical trial consent materials provided by the sponsor.
Announcement line
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07421245?term=medical+device